x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Markets & Money Today | 2 Min News | The Daily News Now!

The Daily News Now!

Stay informed with the latest business, stock market, and finance headlines, updates, and breaking stories delivered daily in quick, engaging episodes. Subscribe!The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

business entrepreneurship

All Episodes

1:36

Karyopharm Therapeutics: Q3 Earnings Snapshot

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Karyopharm Therapeutics, based in Newton, Massachusetts, reported a net loss of $33.1 million for Q3, with a loss of $3.82 per share, surpassing analysts' predictions of $3.30 per share. Despite the higher-than-expected losses, the company's revenue of $44 million exceeded the forecast of $42.3 million, providing a small positive note. The mixed results have left investors and employees uncertain about the company's future direction, with all eyes on Karyopharm as the year progresses.The Daily News

en

1:36

Xanadu Quantum to go public via $3.6 billion SPAC deal

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Xanadu Quantum Technologies, a Canadian quantum computing firm, is set to go public in the US via a merger with Crane Harbor Acquisition Corporation, valued at $3.6 billion. This SPAC merger will raise $500 million for Xanadu, positioning it to compete in the quantum computing race and potentially accelerate quantum advancements as the world demands more computing power.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

en

1:35

TG Therapeutics: Q3 Earnings Snapshot

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

TG Therapeutics, a small-town New York biopharmaceutical company, has made headlines with its impressive third-quarter earnings. The company reported a net income of $390.9 million, surpassing expectations by a significant margin. Earnings per share came in at $2.43, far exceeding the predicted $0.24. Revenue also exceeded predictions, reaching $161.7 million. These results have boosted investor and employee morale, and the market is eagerly awaiting TG Therapeutics' future announcements and

en

1:54

Vertex: Q3 Earnings Snapshot

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Vertex Incorporated, a tax technology and services provider, reported a profit of four million dollars for Q3, matching Wall Street's earnings expectations of seventeen cents per share. Revenue reached one hundred ninety-two point one million dollars, surpassing analysts' estimates. The company expects revenue to remain stable in Q4 and for the full year, indicating consistent performance in a competitive market.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See

en

1:59

Microsoft to invest over $15 billion in UAE, secures...

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Microsoft pledges $15 billion investment in UAE's AI development, focusing on AI data centers and advanced chips. The company secures export licenses for AI chips, marking a significant step in the UAE's mission to become a global AI leader.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

en

2:33

Napco (NASDAQ:NSSC) Beats Expectations in Strong Q3

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Napco, a security systems manufacturer, reported impressive Q3 results, beating Wall Street expectations with a 12% year-over-year sales increase and a 11% higher earnings per share. The company's door-locking products and recurring service subscriptions drove these results, with service revenue making up nearly half its total income. Napco's adjusted EBITDA margin jumped to over 30%, and while free cash flow margin dropped slightly, operating margin remained stable at over 27%. Analysts project an

en

2:22

Debilitado tras derrota electoral, peronismo podría...

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Argentina's Peronist opposition faces a challenging road ahead following their midterm election loss, with President Javier Milei's party gaining momentum. The party is divided, with old rivalries and disagreements hindering unity. They're considering alliances with centrist or center-left groups to challenge Milei, but forming these alliances won't be easy. The Peronists' reputation is damaged by economic woes and corruption scandals, driving voters towards Milei's promises of change. Meanwhile,

en

1:48

Axsome: Q3 Earnings Snapshot

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Axsome Therapeutics reported a Q3 net loss of $47.2 million, or $0.94 per share, missing analysts' expectations of $0.82 per share. However, the company beat revenue forecasts with $171 million, up from $164 million expected. Despite mixed investor reactions, Axsome's stock has surged by 60% this year and 50% over the past year, indicating investor confidence in the company's long-term potential. As the year ends, all eyes are on Axsome to see if its revenue growth can lead to profitability.The

en

1:48

BioCryst: Q3 Earnings Snapshot

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

BioCryst Pharmaceuticals reports a net income of $12.9 million for Q3, marking a turnaround from last year's loss. While earnings of 6 cents per share beat expectations, they still fell short of Wall Street's forecasts. Revenue also came in below expectations at $159.4 million. Despite a 3% stock price drop since January and a 13% drop over the past year, company leaders view this profit as a step forward in their ongoing drug development journey. Investors and analysts will closely watch BioCryst's

en

1:33

Affiliated Managers: Q3 Earnings Snapshot

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Affiliated Managers Group surpasses earnings expectations with a net income of $212.4 million, or $6.87 per share, for the latest quarter. Revenue also topped forecasts at $528 million. The company's stock has been climbing, up 29% since January and 23% in the past year. With strong performance amid market uncertainties, Affiliated Managers Group is gaining attention and keeping investors' interest.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for

en

1:25

Napco: Fiscal Q1 Earnings Snapshot

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Napco Security Technologies, a local tech company in Amityville, New York, has reported a strong start to the year with a net income of $12.2 million and total revenue of $49.2 million for their fiscal first quarter. Known for their innovative security products and systems, Napco's success is attributed to high demand for security technology and their reliable reputation. Investors and analysts are optimistic, but will closely monitor future quarters as market conditions shift.The Daily News Now! —

en

1:40

Bruker: Q3 Earnings Snapshot

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Bruker Corporation, a scientific equipment maker, reported a surprising third-quarter loss, but managed to beat analysts' expectations with adjusted earnings of forty-five cents per share. Despite a drop in stock price, the company's strong sales and positive forecasts for the year have investors watching closely to see if they can turn these surprises into a lasting turnaround.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

en

1:49

Kontoor Brands tops Q3 earnings estimates, raises...

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Kontoor Brands, the parent company of Wrangler, Lee, and Helly Hansen, surprised investors with its Q3 earnings report. Despite slightly missing revenue forecasts, the company topped Wall Street's earnings predictions with adjusted earnings of $1.44 per share. The company attributed this success to its Project Jeanius initiative, which improved gross margin by 80 basis points to 45.8%. Kontoor's ability to adapt and grow profits in a challenging retail environment has earned positive responses from

en

2:08

Powell will ’no doubt be replaced by a Trump...

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

As Chair Jerome Powell's term nears its end, concerns grow over potential changes in leadership at the Federal Reserve. Ed Yardeni from Yardeni Research warns that a Trump loyalist could push for easier monetary policy, risking disagreement within the Fed and harming trust in its decisions. With Powell's term set to end in May 2026, the question of who takes over is raising questions about the future independence of the Federal Reserve.The Daily News Now! — Every city. Every story. AI-powered

en

2:01

uniQure stock plummets after FDA shifts stance on...

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

UniQure's Huntington's Therapy Faces Major Setback: Stock Plummets as FDA Changes Approval StanceThe Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

en

2:29

Palantir, Nvidia, Kenvue and Berkshire Hathaway rise...

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

U.S. stock futures kicked off November with a positive outlook, driven by strong corporate earnings, new deals, and updated guidance from major tech, streaming, and energy companies. Palantir Technologies and Nvidia led the charge, with Palantir's stock climbing over 2% ahead of its quarterly report and Nvidia's shares moving higher despite headline drama over U.S. restrictions on its advanced chips. Berkshire Hathaway's stock rose after reporting a jump in third-quarter profits, while Chinese

en

1:57

Cipher Mining stock soars after signing $5.5 billion...

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Cipher Mining secures a massive 15-year, $5.5 billion deal with Amazon Web Services, marking a significant step forward for both companies in the AI infrastructure space. Cipher will deliver 300 megawatts of capacity using advanced cooling technology, starting in July 2026, and will collect rent from Amazon in August 2026. Additionally, Cipher is expanding its AI presence with a 95% ownership stake in the Colchis project in West Texas and a 10-year hosting deal with Fluidstack and Google. With a

en

2:13

Alvotech stock falls after FDA issues complete...

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Alvotech's new biosimilar drug, AVT zero five, faces a major setback as the FDA sends a complete response letter, citing production issues at the Reykjavik factory. Despite no problems found with the drug application, the facility remains approved for other drugs. The setback disappoints patients and doctors, as a lower-cost version of Simponi could significantly impact overall drug costs for chronic conditions. Alvotech has submitted a plan to the FDA to address the issues and aims to still bring

en

1:46

Microsoft to invest over $15 billion in UAE through...

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Microsoft pledges $15 billion over seven years to expand AI data centers in the UAE, aiming to meet growing demand for AI technology and boost the region's digital transformation. The investment will focus on building new facilities and upgrading existing ones, with the first phase already approved by the US government. This move is expected to bring more jobs and innovation to the region and position the UAE as a major digital hub.The Daily News Now! — Every city. Every story. AI-powered. Hosted on

en

2:01

Pediatrix Medical Group shares surge 10.4% on strong...

Markets & Money Today | 2 Min News | The Daily News Now! ·

2025/11/03

Pediatrix Medical Group's Q3 results exceeded expectations, with adjusted earnings of $0.67 per share, a 20-cent beat, and revenue of $492.8 million, topping estimates. The company attributed this success to strong collection activity, higher patient acuity, and favorable reimbursement factors. Despite a slight drop in overall revenue, growth in the neonatal intensive care unit and modest increase in patient service volumes were highlighted as bright spots. Following the strong quarter, Pediatrix

en

27,890 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...